The Role of Cyberknife Radiosurgery/Radiotherapy for Brain Metastases of Multiple or Large-Size Tumors

Abstract

Objective: Focused, highly targeted radiosurgery and fractionated radiotherapy using the Cyberknife are useful treatments for multiple or large metastases. Here we present our results of Cyberknife^® radiosurgery for 71 patients with 148 metastatic brain lesions. Methods: There were 32 women and 39 men with a median age of 63 (range: 30-88) years. Radiographic follow-up was available for 60 patients with 104 lesions. The mean and median initial volumes of the tumor per lesion were 6.6 and 2.9 cm³ (range: 0.1-53.2 cm³), respectively, at the time of the initial Cyberknife treatment. Forty patients (56%) had a single lesion, and 31 (44%) had multiple lesions (range: 2-7) at initial treatment. The number of fractions ranged from 1 to 3, and forty (27%) of 148 lesions were treated by a fractionated course of Cyberknife therapy. The mean marginal dose was 20.2 Gy (range 7.8-30.1 Gy, median: 20.7 Gy). Results: At 44 weeks of median follow-up, there were no permanent symptoms resulting from radiation necrosis. Overall 6-month and 1-year survival rates were 74% and 47%, respectively, and the median survival time was 56 weeks. The Karnofsky performance score and extracranial metastasis were significant prognostic factors at 6 months and 1 year, respectively, in both univariate and multivariate analyses. Age or multiple metastases did not influence prognosis at 6 months and 1 year. Local control was achieved in 83% (86 lesions). After additional radiosurgical or surgical salvage, no patient died as a result of intracranial disease. Twenty-five patients developed 92 new metastases (range 1-13) outside of the treated lesions with 22.4 weeks of median follow-up. Among them, 21 patients (84 lesions) were treated by salvage Cyberknife. Conclusion: Despite the inclusion of an unfavorable group of patients with large tumors, our results for survival and tumor control rates are comparable to those of published series. The Cyberknife provides the advantage of allowing for fractionated treatment to multiple or large-size tumors.

Key words

Metastatic brain tumor - Cyberknife - radiosurgery - radiotherapy

References

• 1 Alexander E, Moriarty TM, Davis RB, Wen PY, Fine HA, Black PM, Kooy HM, Loeffler JS. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases.  J Natl Cancer Inst. 1995;  87 34-40
• 2 Breneman JC, Warnick RE, Albright RE, Kukiatinant N, Shaw J, Armin D, Tew J. Stereotactic radiosurgery for the treatment of brain metastases. Results of a single institution series.  Cancer. 1997;  79 551-557
• 3 Kim DG, Chung HT, Gwak HS, Paek SH, Jung HW, Han DH. Gamma knife radiosurgery for brain metastases: prognostic factors for survival and local control.  J Neurosurg. 2000;  93 ((Suppl 3)) 23-29
• 4 Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman ML, Shaw EG, Hudgins WR, Weiner R, Harsh GR, Sneed PK. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis.  Int J Radiat Oncol Biol Phys. 1994;  28 797-802
• 5 Adler JR, Cox RS. Preliminary clinical experience with the CyberKnife: image-guided stereotactic radiosurgery. In: Kondziolka D (ed.) Radiosurgery. Basel, Karger 1996: 316-326
• 6 Adler JR. The Cyberknife: a frameless robotic system for radiosurgery.  Stereot Funct Neurosurg. 1997;  69 124-128
• 7 Chang SD, Murphy M, Geis P, Martin DP, Hancock SL, Doty JR, Adler Jr JR. Clinical experience with image-guided robotic radiosurgery (the CyberKnife) in the treatment of brain and spinal cord tumors.  Neurol Med Chirur. 1998;  38 780-783
• 8 Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy.  Brit J Radiol. 1989;  62 679-694
• 9 Cox DR. Regression models and life tables.  J R Stat Soc Series B. 1972;  34 187-202
• 10 Kaplan EL, Meier P. Nonparametric estimation from incomplete observations.  J Am Stat Assoc. 1958;  53 457-481
• 11 Peto R, Peto J. Asymptotically efficient rank invariant test procedures.  J R Stat Soc Series A. 1972;  135 ((Part II)) 185-207
• 12 Sneed PK, Lamborn KR, Forstner JM, McDermott MW, Chang S, Park E, Gutin PH, Phillips TL, Wara WM, Larson DA. Radiosurgery for brain metastases: is whole brain radiotherapy necessary?.  Int J Radiat Oncol Biol Phys. 1999;  43 458-549
• 13 Schoeggl A, Kitz K, Ertl A, Reddy M, Bavinzski G, Schneider B. Prognostic factor analysis for multiple brain metastases after gamma knife radiosurgery: results in 97 patients.  J Neurooncol. 1999;  42 169-175
• 14 Shiau CY, Sneed PK, Shu HK, Lamborn KR, McDermott MW, Chang S, Nowak P, Petti PL, Smith V, Verhey LJ, Ho M, Park E, Wara WM, Gutin PH, Larson DA. Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control.  Int J Radiat Oncol Biol Phys. 1997;  37 375-383
• 15 Serizawa T, Iuchi T, Ono J, Saeki N, Osato K, Odaki M, Ushikubo O, Hirai S, Sato M, Matsuda S. Gamma knife treatment for multiple metastatic brain tumors compared with whole-brain radiation therapy.  J Neurosurg. 2000;  93 ((Suppl 3)) 32-36
• 16 Suzuki S, Omagari J, Nishio S, Nishiye E, Fukui M. Gamma knife radiosurgery for simultaneous multiple metastatic brain tumors.  J Neurosurg. 2000;  93 ((Suppl 3)) 30-31
• 17 Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases.  Int J Radiat Oncol Biol Phys. 1999;  45 427-434
• 18 Auchter RM, Lamond JP, Alexander E, Buatti JM, Chappell R, Friedman WA, Kinsella TJ, Levin AB, Noyes WR, Schultz CJ, Loeffler JS, Mehta MP. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis.  Int J Radiat Oncol Biol Phys. 1996;  35 27-35
• 19 Pirzkall A, Debus J, Lohr F, Fuss M, Rhein B, Engenhart-Cabillic R, Wannenmacher M. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases.  J Clin Oncol. 1998;  16 3563-3569
• 20 Buatti JM, Friedman WA, Bova FJ, Mendenhall WM. Treatment selection factors for stereotactic radiosurgery of intracranial metastases.  Int J Radiat Oncol Biol Phys. 1995;  32 1161-1166
• 21 Cho KH, Hall WA, Gerbi BJ, Higgins PD, Bohen M, Clark HB. Patient selection criteria for the treatment of brain metastases with stereotactic radiosurgery.  J Neurooncol. 1998;  40 73-86
• 22 Coffey RJ, Flickinger JC, Bissonette DJ, Lunsford LD. Radiosurgery for solitary brain metastases using the cobalt-60 gamma unit: methods and results in 24 patients.  Int J Radiat Oncol Biol Phys. 1991;  20 1287-1295
• 23 Davey P, O'Brien PF, Schwartz ML, Cooper PW. A phase I/II study of salvage radiosurgery in the treatment of recurrent brain metastases.  Brit J Neurosurg. 1994;  8 717-723

Correspondence